long term effects of glp-1 drugs Your guide to side Common, uncommon, and rare side

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Download it once and read it on your Kindle device, PC, phones or tablets

The best results happen when the medicine is used along with healthy eating and exercise, and people may gain weight back if they stop taking the medicine

A 2026 analysis of 25 products found zero contained semaglutide

A state-by-state look at how affordable GLP-1 drugs like Ozempic and Zepbound really are and where cost keeps patients from access.

Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health care spending.